|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 13722217.0 (espacenet) (Federated) (European Patent Register), 20130430 | | Patent/reg. no. and date | DK/EP 2846780, 20180718 | | Publication date | 20150318 | | Priority no. and date | US 201261643454 P, 20120507 | | EP pub. no. and date |
EP 2846780 20150318 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | V145779 | | Inventor | PERRONE, Robert Kevin, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4709 (2006.01) , A61K 9/48 (2006.01) , A61P 31/14 (2006.01) | | Title | OPLØST KAPSELFORMULERING AF 1,1-DIMETHYLETHYL[(1S)-1-{[(2S,4R)-4-(7-CHLOR-4-
METHOXYISOQUINOLIN-1-YLOXY)-2-({(1R,2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-
2-ETHENYLCYCLOPROPYL}CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-
DIMETHYLPROPYL]CARBAMAT | | Int. application no. | US2013038770 | | Int. publication no. | WO2013169520 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
